Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

NKTX US Equity

Nkarta, Inc.Health Care · Pharmaceutical Preparations · CIK 1787400 · FY ends Dec 31
$2.54
+0.13 (+5.39%)
USD · as of 2026-08-19 · marketstack
6 8-K filings · 2 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-06-118-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-1913D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by New Enterprise Associates 15, L.P.sec.gov ↗
2026-05-128-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-03-258-K 8.01Other eventssec.gov ↗
2026-03-258-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by TANG CAPITAL MANAGEMENT LLCsec.gov ↗
2025-11-2413D/ASchedule 13D amendment — ≥5% beneficial owner (active intent) · by Samsara BioCapital, L.P.sec.gov ↗
2025-11-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by CITADEL ADVISORS LLCsec.gov ↗
2025-11-108-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-10-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by BlackRock, Inc.sec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-10-17

Every row is a filed document, checked against its EDGAR index.